Brind.

Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.

1 report, 1 independent Updated Sep 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Grifols Spain MarketBeat

Keep exploring

The entities involved

Grifols
Spanish pharmaceutical company
- Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.Fri 17:53
Spain
country in southwestern Europe with territories in Africa
- A heat dome is affecting Spain, Italy, and the UK, prompting weather warnings across Europe.Mon 17:01
- Spain's Sira Rego made controversial remarks about the Palestinian state, leading Israel to summon the Spanish embassy and expel diplomats from Ramallah.Mon 14:44
MarketBeat
American personal finance blog
- Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
- MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15

Related events

Coverage

Newest first; wire copies grouped

Sep 1themarketsdaily.com